Patents by Inventor Hidezo Mori

Hidezo Mori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9782439
    Abstract: Mesenchymal stem cells are pluripotent cells capable of differentiating into myocardial and vascular endothelial cells. The present invention demonstrates that the mesenchymal stem cell sheet have therapeutic potential for a severely damaged heart due to its pluripotency and in situ self-renewal capability. Mesenchymal stem cells derived from adipose tissue were cultured to prepare a mesenchymal stem cell sheet. Four weeks after induction of myocardial infarction in rats, the mesenchymal stem cell sheet was transplanted to the heart. The mesenchymal stem cell sheet were readily engrafted to the surface of the scarred myocardium, grew gradually in situ, and formed a thick layer (approximately 600 ?m) in 4 weeks. The grown transplanted mesenchymal tissue contained newly formed blood vessels, myocardial cells, and undifferentiated mesenchymal cells.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: October 10, 2017
    Assignee: JAPAN HEALTH SCIENCES FOUNDATION
    Inventors: Noritoshi Nagaya, Hidezo Mori, Yoshinori Miyahara
  • Publication number: 20090203768
    Abstract: A nucleic acid-containing complex, containing a nucleic acid and a biodegradable polymer, especially a positively-charged water-insoluble biodegradable polymer, is disclosed. The complex has excellent properties of sustainedly releasing a desired nucleic acid, especially DNA, to a site in need of a treatment. Since the complex can be taken up to phagocytes such as macrophages and delivered specifically to the target site, the function of the nucleic acid can be exhibited in a target site specific manner, and thus more specific gene therapy can be achieved. The complex has no adverse effects, such as occurrence of recombinants or toxicity which could be caused by using a virus vector such as adenovirus, or liposome. Thus, the complex is particularly preferable for the field of gene therapy. Furthermore, the complex enhances the biological effect of the nucleic acid introduced into the cells, allowing a gene therapy with a lower dose of nucleic acids.
    Type: Application
    Filed: April 25, 2007
    Publication date: August 13, 2009
    Inventors: Hidezo Mori, Yasuhiko Tabata, Kiyoshi Ando, Etsuro Tanaka, Harukazu Iseki, Hiromi Sakamoto, Naoto Fukuyama, Hirofumi Kasahara
  • Patent number: 7276594
    Abstract: A nucleic acid-complex, containing a nucleic acid and a positively charged, water-insoluble biodegradable polymer, is disclosed. The complex has properties of sustainedly releasing a desired nucleic acid, especially DNA, to a site. The complex can be taken up by phagocytes such as macrophages and delivered to a target site, allowing the function of the nucleic acid to be exhibited in a target specific manner.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: October 2, 2007
    Assignee: CMIC Company, Ltd.
    Inventors: Hidezo Mori, Yasuhiko Tabata, Kiyoshi Ando, Etsuro Tanaka, Harukazu Iseki, Hiromi Sakamoto, Naoto Fukuyama, Hirofumi Kasahara